What type of study is this?

This is a Quantitative Study study.

Perspectives on OncomiR and TSmiRs in Breast Cancer and Assessment of their Regulatory Network

View Full Paper

Ask AI

Bookmark

OncomiRs facilitate cell proliferation and metastasis in breast cancer, suppressing tumor suppressor genes.
Synthetic anti-miRs inhibit OncomiRs binding to target RNAs, effectively suppressing cancer cell growth.
TSmiRs decreased levels promote cancer progression by failing to inhibit cancer-promoting genes.
Circulating miRNAs offer a stable, non-invasive biomarker option for early detection in breast cancer.

No takes yet. Share an insight, caveat, or question.

Overview of miRNAs' impact on breast cancer progression and potential as non-invasive biomarkers.

Phoebe et al. (2024) studied this question.

View Full Paper

Ask AI

Bookmark